glp 1 glucagon Glucagon-like peptide in health and disease Glucagon-like peptide (GLP)-1 and GLP-2

Instead, pick light, simple options with neutral flavors like a turkey sandwich or soup

Once cleared, some forms of lip pigmentation will not recur

In addition, these therapies reduce glucagon secretion and delay gastric emptying, facilitating weight reduction through a neuronally mediated satiety effect [1, 2]

The initial twice-daily formulation was discontinued due to exceptionally high rates of gastrointestinal adverse events (nausea and vomiting), leading to discontinuation rates exceeding 50% in trials

Most critically, patients with active malignancies or significant cancer risk factors may not be appropriate candidates due to the potential for promoting tumor growth and metastasis through angiogenesis stimulation